FSD Pharma Inc. (NASDAQ: HUGE)
$0.15
+0.0029 ( +2.01% ) 614.3K
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Market Data
Open
$0.15
Previous close
$0.14
Volume
614.3K
Market cap
$6.82M
Day range
$0.14 - $0.15
52 week range
$0.13 - $1.68
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
20-f | Annual reports | 177 | Apr 02, 2024 |
6-k | Quarterly Reports | 3 | Mar 27, 2024 |
6-k | Quarterly Reports | 3 | Mar 11, 2024 |
6-k | Quarterly Reports | 3 | Mar 05, 2024 |
6-k | Quarterly Reports | 3 | Feb 28, 2024 |
6-k | Quarterly Reports | 3 | Feb 26, 2024 |
6-k | Quarterly Reports | 1 | Feb 22, 2024 |
6-k | Quarterly Reports | 6 | Feb 20, 2024 |
6-k | Quarterly Reports | 3 | Feb 20, 2024 |
6-k | Quarterly Reports | 3 | Feb 07, 2024 |